DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABACAVIR SULFATE;LAMIVUDINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ABACAVIR SULFATE;LAMIVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PREDNISOLONE STEAGLATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PREDNISOLONE STEAGLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
OZQ2XN817F
Molecule Type:
Small molecule
Molecular Formula:
C41H64O8
Molecular Weight:
684.95
AlogP:
7.91
PSA:
127.2
HBD:
2.0
HBA:
#RotB:
21.0
Source:
PENTASTARCH
4
Oligosaccharide
Approved
Unknown
Unknown
Unknown
Unknown
PENTASTARCH
×
Maximum Phase:
4
First Approval:
None
UNII:
MOQ3RNM0SV
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAPT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
DAPT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PYRANTEL PAMOATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PYRANTEL PAMOATE
×
Maximum Phase:
4
First Approval:
None
UNII:
81BK194Z5M
Molecule Type:
Small molecule
Molecular Formula:
C34H30N2O6S
Molecular Weight:
594.69
AlogP:
2.5
PSA:
15.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
SODIUM PERBORATE
4
Small molecule
Approved
Unknown
Unknown
Infections
Unknown
SODIUM PERBORATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Y52BK1W96C
Molecule Type:
Small molecule
Molecular Formula:
H4B2Na2O8
Molecular Weight:
199.63
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ISOCONAZOLE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ISOCONAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
GRI7WFR424
Molecule Type:
Small molecule
Molecular Formula:
C18H14Cl4N2O
Molecular Weight:
416.14
AlogP:
6.45
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
6.0
Source:
MECASERMIN RINFABATE RECOMBINANT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MECASERMIN RINFABATE RECOMBINANT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCORTISONE ACETATE; UREA
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
HYDROCORTISONE ACETATE; UREA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M SODIUM PERTECHNETATE
4
Small molecule
Approved
OTHER
INJECTION; ORAL
Unknown
Unknown
TECHNETIUM TC-99M SODIUM PERTECHNETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ALA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOFETAMINE HYDROCHLORIDE I-123
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IOFETAMINE HYDROCHLORIDE I-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANTHRALIN
4
Small molecule
Approved
Unknown
Unknown
Psoriasis
Unknown
ANTHRALIN
×
Maximum Phase:
4
First Approval:
None
UNII:
U8CJK0JH5M
Molecule Type:
Small molecule
Molecular Formula:
C14H10O3
Molecular Weight:
226.23
AlogP:
2.23
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
0.0
Source:
DIBROMSALAN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DIBROMSALAN
×
Maximum Phase:
4
First Approval:
None
UNII:
N9900K2RBT
Molecule Type:
Small molecule
Molecular Formula:
C13H9Br2NO2
Molecular Weight:
371.03
AlogP:
4.17
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
DOSTARLIMAB-GXLY
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
DOSTARLIMAB-GXLY
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM IODIDE I 131
4
Small molecule
Approved
Unknown
Unknown
Hyperthyroidism; Thyroid Neoplasms
Unknown
SODIUM IODIDE I 131
×
Maximum Phase:
4
First Approval:
None
UNII:
29VCO8ACHH
Molecule Type:
Small molecule
Molecular Formula:
INa
Molecular Weight:
153.9
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SOC
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SOC
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M RED BLOOD CELL KIT
4
Unknown
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M RED BLOOD CELL KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BILASTINE
4
Small molecule
Approved
Unknown
Unknown
Conjunctivitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria; Hypersensitivity
Histamine H1 receptor inverse agonist
BILASTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
PA1123N395
Molecule Type:
Small molecule
Molecular Formula:
C28H37N3O3
Molecular Weight:
463.62
AlogP:
4.86
PSA:
67.59
HBD:
1.0
HBA:
#RotB:
10.0
Source:
MENATETRENONE
4
Small molecule
Approved
Unknown
Unknown
Carcinoma, Hepatocellular; Renal Insufficiency, Chronic; Thrombosis; Osteoporosis; Osteoporosis, Postmenopausal
Unknown
MENATETRENONE
×
Maximum Phase:
4
First Approval:
None
UNII:
27Y876D139
Molecule Type:
Small molecule
Molecular Formula:
C31H40O2
Molecular Weight:
444.66
AlogP:
8.92
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
11.0
Source:
INSULIN GLARGINE; LIXISENATIDE
4
Combination
Approved
Unknown
SUBCUTANEOUS
Unknown
Unknown
INSULIN GLARGINE; LIXISENATIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALAMINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CALAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETIC ACID
4
Small molecule
Approved
Unknown
Unknown
Chemical and Drug Induced Liver Injury; Inflammation
Unknown
ACETIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Q40Q9N063P
Molecule Type:
Small molecule
Molecular Formula:
C2H4O2
Molecular Weight:
60.05
AlogP:
0.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ROMOSOZUMAB-AQQG
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ROMOSOZUMAB-AQQG
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINOBENZOIC ACID
4
Small molecule
Unknown
Unknown
Unknown
Unknown
Unknown
AMINOBENZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
TL2TJE8QTX
Molecule Type:
Small molecule
Molecular Formula:
C7H7NO2
Molecular Weight:
137.14
AlogP:
0.97
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
LAMIVUDINE; ZIDOVUDINE
4
Combination
Approved
IMMUNE SYSTEM; OTHER
ORAL; ORAL SUSPENSION
Unknown
Unknown
LAMIVUDINE; ZIDOVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COPPER
4
Small molecule
Approved
OTHER
INTRAUTERINE
Vaginosis, Bacterial; Amyotrophic Lateral Sclerosis; Multiple Myeloma; Neoplasms; Prostatic Neoplasms, Castration-Resistant; Alzheimer Disease; Breast Neoplasms; Glioblastoma
Unknown
COPPER
×
Maximum Phase:
4
First Approval:
None
UNII:
789U1901C5
Molecule Type:
Small molecule
Molecular Formula:
Cu+2
Molecular Weight:
63.55
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ACEMETACIN
4
Small molecule
Approved
Unknown
Unknown
Rheumatic Diseases
Cyclooxygenase inhibitor
ACEMETACIN
×
Maximum Phase:
4
First Approval:
None
UNII:
5V141XK28X
Molecule Type:
Small molecule
Molecular Formula:
C21H18ClNO6
Molecular Weight:
415.83
AlogP:
3.47
PSA:
94.83
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BUTETHAL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BUTETHAL
×
Maximum Phase:
4
First Approval:
None
UNII:
OHZ8QAW6YC
Molecule Type:
Small molecule
Molecular Formula:
C10H16N2O3
Molecular Weight:
212.25
AlogP:
0.94
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
4.0
Source:
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROSE; POTASSIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; POTASSIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
QUININE DIHYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
QUININE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
8C3EMH7D9X
Molecule Type:
Small molecule
Molecular Formula:
C20H26Cl2N2O2
Molecular Weight:
397.35
AlogP:
3.17
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
294
295
296
297
298
299
300
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA